REBECCA HARRIS: Open Payments
NPI 1235553462 · WIGGINS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 24 payments from 8 companies in 2025. Trend: 2023 $277 · 2024 $305 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $188 |
| ABBVIE INC. | 13 | $144 |
| Janssen Biotech, Inc. | 2 | $133 |
| Amgen Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $30 |
| Exact Sciences Corporation | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Insulet Corporation | 1 | $15 |
Products named: BREZTRI, VRAYLAR, TREMFYA, AIRSUPRA, EVENITY, MOUNJARO, Cologuard Collection Kit, UBRELVY.
Industry payments across MS — which companies pay providers there.
